Daniel Ek’s Neko Health raises $65M for AI-powered preventative health solutions

Daniel Ek's Neko Health raises $65M for AI-powered preventative health solutions

Join top executives in San Francisco July 11-12 and learn how business leaders are anticipating the generative AI revolution. Learn more

Neko Salute, a healthcare technology company co-founded by Hjalmar Nilsonne and Spotify founder Daniel Ek, has announced the successful completion of a €60 million ($65 million) Series A financing round. The company aims to revolutionize the healthcare industry through artificial intelligence (AI)-guided whole-body scans, with a particular focus on preventive healthcare.

The funding marks the company’s first external equity infusion. The round was led by Star of the lakewith the participation of investment firms Atomic and general catalyst.

Klaus Hommels of Lakestar and Niklas Zennström, co-founder of Skype and CEO of Atomico, will join the company’s board following the investment.

Neko Health has introduced an innovative medical scanning technology that enables non-invasive and extensive collection of health data, prioritizing speed, accuracy and convenience.


Transform 2023

Join us in San Francisco July 11-12, where top executives will share how they integrated and optimized AI investments for success and avoided common pitfalls.

subscribe now

The company operates private clinics with proprietary, out-of-the-box diagnostic products, including its own integrated 360-degree full-body 3D scanner with over 70 sensors. The scanner can collect 50 million data points in minutes.

This data is analyzed by a “self-learning AI-powered system,” which provides doctors and patients with insights.

“Doctors today don’t have enough time or resources to focus on prevention. This causes many health problems to go unnoticed until they become really serious, causing a lot of pain and putting a strain on the healthcare system,” said Hjalmar Nilsonne, CEO and co-founder of Neko Health, in a written statement.

While similar technology has emerged in the past, as a collaboration between Facebook and New York University to increase the speed of MRI scans using AINeko distinguishes itself by implementing this technology on a larger scale and in a more readily available way.

Delivering Intricate Health Insights Through Artificial Intelligence

The company says its new AI platform enables early detection of health issues by analyzing scan results and providing immediate results related to possible issues ranging from skin conditions to cardiovascular health.

Clients receive the results during the appointment and can access and track them through a dedicated app.

According to Neko Health, each scan takes about 10 minutes and costs 250 euros. Afterwards, patients undergo an in-person consultation, where the results are explained in detail.

“In Sweden, healthcare costs have risen 50% faster than GDP since 2000, and in 28 of the 32 EU countries, the increase has been even faster. This has placed an unreasonable burden on medical staff who must do more each year and less resources than ever before for prevention and public health,” Nilsonne said in a LinkedIn posts. “Solving this is one of the most important and difficult problems for humanity in the future. We believe the solution is to move away from reactive treatment of the sick and move towards prevention and helping people stay healthy.”

The company opened its inaugural clinic in Stockholm in February. It has since performed more than 1,000 scans, with many people currently on waiting lists, according to Neko Health.

The company also said that about 80% of customers have paid upfront for follow-up scans to be done within a year.

Nilsonne said the company has already demonstrated the resonance of its unique approach to preventive health care. The strong demand signals a real need and desire for change, which has prompted the company to broaden its horizons and accelerate its growth by forming partnerships with external investors for the first time.

Neko Health said the new secured funding will drive the company’s strategic expansion plans, continued investment in research and development, clinical trials and the acquisition of top-level talent.

VentureBeat’s mission it is to be a digital city square for technical decision makers to gain insights into transformative business technology and transactions. Discover our Briefings.